Moderna | MRNA - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celltrion KRW 10.5B 4.1B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Moderna USD -799M 612M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pharma Mar EUR 1.6M 38.6M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Qiagen NV USD 109.17M 25.56M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Sartorius EUR 157.8M 76.1M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03